Home›Companies›BioLoomics

BioLoomics, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 10, 2025·Suggest an edit

About BioLoomics

BioLoomics is a private company based in Boulder, Colorado. It has reported $10,974,939 raised in four offerings on Form D since June 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 11, 2025Nov 10, 2025$450,000of $2.0M target5$90,000Options, Securities on exerciseRule 506(b)Form D ↗
Feb 24, 2023Mar 13, 2023$9,349,939of $9.9M target23$406KEquityRule 506(b)Form D ↗
May 11, 2021May 17, 2021$575,000fully sold11$52,273OptionsRule 506(b)Form D ↗
May 30, 2019Jun 10, 2019$600,000fully sold8$75,000EquityRule 506(b)Form D ↗
Total, four offerings$10,974,939

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BioLoomics's Form D filed Nov 10, 2025.

DC
Douglas Chapnick
85 Forrest Lane Boulder, Co 80302 and director
JD
Joel Dudley
Director

Sources

  1. SECBioLoomics, Inc. filing history